Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3967551 | 0.89 | MAPK1 (0.58) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL14439499 | 0.88 | HSD17B10 (0.68) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL3966130 | 0.87 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768683 | 0.87 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768420 | 0.87 | MAPK1 (0.53) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768785 | 0.86 | MAPK1 (0.55) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768520 | 0.85 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768787 | 0.85 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768423 | 0.85 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768521 | 0.85 | MAPK1 (0.53) | MAPK1HSD17B10KMT2ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1509513-B1 | MICROBICIDAL OXATHIINCARBOXAMIDES | BAYER CROPSCIENCE AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| US-7119049-B2 | Oxathiinecarboxamides | BAYER CROPSCIENCE AG (DE) | 2006-10-10 | — | — | US | disclosed |
| US-20050203171-A1 | Oxathiincarboxamides | BAYER CROPSCIENCE AG (DE) | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203171-A1 | Oxathiincarboxamides | MRPL21, ODC1, DDT | MAPK1 4217/4885HSD17B10 3440/4885KMT2A 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.